­
­
­
­

Inventi Impact: Infectious Diseases & Immunology

Articles

  • Inventi:hidi/22773/17
    Potential Role of Carvedilol in the Cardiac Immune Response Induced by Experimental Infection\nwith Trypanosoma cruzi
    01-Jan-1970 Research 2017 : July - September
    Aline Luciano Horta, Ana Luisa Junqueira Leite, G Paula Costa, Vivian Paulino Figueiredo, Andre Talvani

    Trypanosoma cruzi causes a cardiac infection characterized by an inflammatory imbalance that could become the inciting factor\nof the illness. To this end, we evaluated the role of carvedilol, a beta-blocker with potential immunomodulatory properties, on the\nimmune response in C57BL/6 mice infected with VL-10 strain of T. cruzi in the acute phase. Animals (

    How to Cite this Article
    CC Compliant Citation: Aline Luciano Horta, Ana Luisa Junqueira\nLeite, G. Paula Costa, Vivian Paulino Figueiredo, and André\nTalvani, â??Potential Role of Carvedilol in the Cardiac Immune\nResponse Induced by Experimental Infection with Trypanosoma\ncruzi,â? BioMed Research International, vol. 2017, Article ID\n9205062, 7 pages, 2017. doi:10.1155/2017/9205062, http://\ncreativecommons.org/licenses/by/4.0/.
    Download Full Text